Rankings
▼
Calendar
WGS Q1 2024 Earnings — GeneDx Holdings Corp. Revenue & Financial Results | Market Cap Arena
WGS
GeneDx Holdings Corp.
$3B
Q1 2024 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$62M
+44.7% YoY
Gross Profit
$37M
59.9% margin
Operating Income
-$14M
-21.9% margin
Net Income
-$20M
-32.4% margin
EPS (Diluted)
$-0.78
QoQ Revenue Growth
+8.7%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$17M
Stock-Based Comp.
-$451,000
Balance Sheet
Total Assets
$395M
Total Liabilities
$187M
Stockholders' Equity
$207M
Cash & Equivalents
$84M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$62M
$43M
+44.7%
Gross Profit
$37M
$15M
+145.5%
Operating Income
-$14M
-$60M
+77.4%
Net Income
-$20M
-$61M
+66.8%
← FY 2024
All Quarters
Q2 2024 →